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The identification of all 
cellular targets of 
biologically active small 
molecules not only 
plays a pivotal role in 
the development of 
new drugs but also 
provides information for 
the potential use of 
known drugs for the 
treatment of other 
medical conditions 
through the modulation 
of new targets. 
MASPIT
[1]
, a three hybrid technique based on the cytokine 
receptors JAK/STAT system allows rapid intracellular 
screening for targets of small molecules against a large 
collection of specifically modified humane cytosolic proteins 
with simple photometric readout. To this end a multifunctional 
methotrexate reagent was designed and synthesized which in 
turn allowed for validation of the MASPIT assay using FK506 
as the pilot compound.  
[1] Caligiuri, M.et al. Chem. Biol. 2006, 13, 711–722. 
